N.A. ElSayed, G. Aleppo, V.R. Aroda, R.R. Bannuru, F.M. Brown, D. Bruemmer et al., 2.Classification and diagnosis of diabetes: standards of care in diabetes–2023. Diabetes Care 46, S19–S40 (2023). https://doi.org/10.2337/dc23-S002.

Article  CAS  PubMed  Google Scholar 

American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33, S62–S69 (2010). https://doi.org/10.2337/dc10-S062.

Article  PubMed Central  Google Scholar 

K. Faerch, K. Borch-Johnsen, J.J. Holst, A. Vaag, Pathophysiology and aetiology of impaired glucose tolerance: does it matter for treatment and prevention of type 2 diabetes. Diabetologica 52, 1714–1723 (2009). https://doi.org/10.1007/s00125-009-1443-3.

Article  CAS  Google Scholar 

B. Richter, B. Hemmingsen, M.I. Metzendorf, Y. Takwoingi, Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst. Rev. 10, CD012661 (2018). https://doi.org/10.1002/14651858.CD012661.pub2.

Article  PubMed  Google Scholar 

T. Sathish, K. Khunti, K.M.V. Narayan, V. Mohan, M.J. Davies, T. Yates et al., Effect of conventional lifestyle interventions on type 2 diabetes incidence by glucose-defined prediabetes phenotype: an individual participant data meta-analysis of randomized controlled trials. Diabetes Care 46, 1903–1907 (2023). https://doi.org/10.2337/dc23-0696.

Article  PubMed  PubMed Central  Google Scholar 

M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007). https://doi.org/10.1056/NEJMra070553.

Article  CAS  PubMed  Google Scholar 

K.C. Chiu, A. Chu, V.L. Go, M.F. Saad, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79, 820–825 (2004). https://doi.org/10.1093/ajcn/79.5.820.

Article  CAS  PubMed  Google Scholar 

S. Kayaniyil, R. Vieth, R. Retnakaran, J.A. Knight, Y. Qi, H.C. Gerstein et al., Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33, 1379–1381 (2010). https://doi.org/10.2337/dc09-2321.

Article  PubMed  PubMed Central  Google Scholar 

A. Shankar, C. Sabanayagam, S. Kalidindi, Serum 25-hydroxyvitamin D levels and prediabetes among subjects free of diabetes. Diabetes Care 34, 1114–1119 (2011). https://doi.org/10.2337/dc10-1203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Jorde, S.T. Sollid, J. Svartberg, H. Schirmer, R.M. Joakimsen, I. Njølstad et al., Vitamin D 20,000 IU per week for five years does not prevent progression from prediabetes to diabetes. J. Clin. Endocrinol. Metab. 101, 1647–1655 (2016). https://doi.org/10.1210/jc.2015-4013.

Article  CAS  PubMed  Google Scholar 

T. Kawahara, Eldecalcitol, a vitamin D analog, for diabetes prevention in impaired glucose tolerance (DPVD study) (Abstract). Diabetes 67, 120-LB (2018).

Article  Google Scholar 

A.G. Pittas, B. Dawson-Hughes, P. Sheehan, J.H. Ware, W.C. Knowler, V.R. Aroda et al., Vitamin D supplementation and prevention of type 2 diabetes. N. Engl. J. Med. 381, 520–530 (2019). https://doi.org/10.1056/NEJMoa1900906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

G. Zipf, M. Chiappa, K.S. Porter, Y. Ostchega, B.G. Lewis, J. Dostal, National health and nutrition examination survey: plan and operations, 1999–2010. Vital. Health Stat. 1, 1–37 (2013).

Google Scholar 

J. Mitri, A.G. Pittas, Vitamin D and diabetes. Endocrinol. Metab. Clin. North. Am. 43, 205–232 (2014). https://doi.org/10.1016/j.ecl.2013.09.010.

Article  PubMed  Google Scholar 

M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney et al., Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011). https://doi.org/10.1210/jc.2011-0385.

Article  CAS  PubMed  Google Scholar 

National Health and Nutrition Examination Survey (2011). https://www.cdc.gov/nchs/nhanes/.

A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine:a new prediction equation. Ann. Intern. Med. 130, 461–470 (1999). https://doi.org/10.7326/0003-4819-130-6-199903160-00002.

Article  CAS  PubMed  Google Scholar 

A. Tura, E. Grespan, C.S. Göbl, R.W. Koivula, P.W. Franks, E.R. Pearson et al., Profiles of glucose metabolism in different prediabetes phenotypes, classified by fasting glycemia, 2-hour OGTT, glycated hemoglobin, and 1-hour OGTT: an IMI DIRECT study. Diabetes 70, 2092–2106 (2021). https://doi.org/10.2337/db21-0227.

Article  CAS  PubMed  Google Scholar 

A. Tura, C. Gobl, E. Moro, G. Pacini, Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin. Endocr. J. 64, 117–122 (2017). https://doi.org/10.1507/endocrj.EJ16-0298.

Article  CAS  PubMed  Google Scholar 

L. Perreault, K. Færch, Approaching pre-diabetes. J. Diabetes Complications 28, 226–233 (2014). https://doi.org/10.1016/j.jdiacomp.2013.10.008.

Article  PubMed  Google Scholar 

D.C. Ziemer, P. Kolm, W.S. Weintraub, V. Vaccarino, M.K. Rhee, J.G. Twombly et al., Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann. Intern. Med. 152, 770–777 (2010). https://doi.org/10.7326/0003-4819-152-12-201006150-00004.

Article  PubMed  Google Scholar 

W.H. Herman, Y. Ma, G. Uwaifo, S. Haffner, S.E. Kahn, E.S. Horton et al., Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care 30, 2453–2457 (2007). https://doi.org/10.2337/dc06-2003.

Article  CAS  PubMed  Google Scholar 

M.D. Campbell, T. Sathish, P.Z. Zimmet, K.R. Thankappan, B. Oldenburg, D.R. Owens et al., Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype. Nat. Rev. Endocrinol. 16, 395–400 (2020). https://doi.org/10.1038/s41574-019-0316-1.

Article  CAS  PubMed  Google Scholar 

S. Qiu, X. Cai, X. Zhou, J. Xu, Z. Sun, H. Guo et al., Muscle quality in relation to prediabetes phenotypes: a population-based study with mediation analysis. J. Clin. Endocrinol. Metab. 109, e1151–e1158 (2024). https://doi.org/10.1210/clinem/dgad630.

Article  PubMed  Google Scholar 

R.M. Pojednic, E.M. Trussler, J.D. Navon, S.C. Lemire, E.C. Siu, E.S. Metallinos-Katsaras, Vitamin D deficiency associated with risk of prediabetes among older adults: data from the National Health and Nutrition Examination Survey (NHANES), 2007–2012. Diabetes Metab. Res. Rev. 38, e3499 (2022). https://doi.org/10.1002/dmrr.3499.

Article  CAS  PubMed  Google Scholar 

M.R. Rooney, L. Harnack, E.D. Michos, R.P. Ogilvie, C.T. Sempos, P.L. Lutsey, Trends in use of high-dose vitamin D supplementsexceeding 1000 or 4000 international units daily, 1999–2014. JAMA 317, 2448–2450 (2017). https://doi.org/10.1001/jama.2017.4392.

Article  PubMed  PubMed Central  Google Scholar 

H.F. DeLuca, Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80, 1689S–1696SS (2004). https://doi.org/10.1093/ajcn/80.6.1689S.

Article  CAS  PubMed  Google Scholar 

J. MacLaughlin, M.F. Holick, Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest. 76, 1536–1538 (1985). https://doi.org/10.1172/JCI112134.

Article  CAS  PubMed  PubMed Central  Google Scholar 

A.G. Pittas, R. Jorde, T. Kawahara, B. Dawson-Hughes, Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D?. J. Clin. Endocrinol. Metab. 105, 3721–3733 (2020). https://doi.org/10.1210/clinem/dgaa594.

Article  PubMed  PubMed Central  Google Scholar 

J.S. Walsh, S. Bowles, A.L. Evans, Vitamin D in obesity. Curr. Opin. Endocrinol. Diabetes Obes. 24, 389–394 (2017). https://doi.org/10.1097/MED.0000000000000371.

Article